FSH (Follicle-Stimulating Hormone)

Hormones

Female Hormones

Follicle-Stimulating Hormone (FSH) is released by the pituitary gland to drive follicle development in the ovaries. As ovarian function declines, FSH rises dramatically, making it a key signal of the menopausal transition. Preventive practices track it to help stage reproductive aging and interpret other hormone results.

What It Measures

Pituitary hormone driving follicle development; rises dramatically in menopause as ovarian function declines

Optimal vs. Lab Range

Longevity Optimal

Phase-dependent

Target range for optimal health and longevity based on research.

Standard Lab

3–20 IU/L (premenopausal)

Population-based reference range from standard labs.

Why It Matters

FSH reflects the conversation between the pituitary and the ovaries, so its pattern reveals where a woman is in her reproductive lifespan. Elevated levels, particularly above the menopausal threshold, indicate declining ovarian function, primary ovarian insufficiency, or menopause. Low FSH can point to pituitary dysfunction, hypothalamic amenorrhea, or the effects of extreme stress, undernutrition, or eating disorders. Because FSH is cycle-dependent in premenopausal women, timing of the draw matters for accurate interpretation. Read together with LH, estradiol, and AMH, it helps clarify fertility status and guides timely attention to the health shifts that accompany estrogen decline.

When Low

Pituitary dysfunction, hypothalamic amenorrhea, anorexia, extreme stress

When High

Menopause (>30 IU/L), primary ovarian insufficiency, Turner syndrome

How to Optimize

FSH is primarily a diagnostic signal rather than a target to adjust directly. When results reflect menopause, physician-directed hormone replacement therapy may be considered for symptom and healthspan support; when they reflect hypothalamic suppression, addressing stress, nutrition, and energy availability is central. Fertility preservation may be discussed where relevant. Hormone testing and treatment must be individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

HRT (clinical)

fertility preservation

lifestyle optimization

Linked Compounds & Supplements

Vitex

Maca

DHEA (clinical)

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum; saliva for diurnal cortisol panels

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Semi-annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift FSH (Follicle-Stimulating Hormone).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.